Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document
 
 

6.02   LICENSEE shall pay to OHSU an additional license royalty in the amount of Twenty Thousand U.S. Dollars (US $20,000) upon receipt of pair of MICE under the option described in Paragraph 3.01.1. LICENSEE shall pay to OHSU a further license royalty in the amount of Twenty Thousand U.S. Dollars (US $20,000) per pair upon receipt of any additional pair of MICE. LICENSEE shall pay all transportation costs for shipment of any MICE from OHSU to LICENSEE. However, no additional royalties shall be due for a pair of MICE received as replacement for an Unsuccessful Breeding Pair under Paragraph 3.01.1, and such a replacement pair of MICE shall be shipped to LICENSEE at OHSU’s expense.
 
6.03   LICENSEE agrees to pay OHSU an earned royalty of [***] percent ([***]%) percent on Net Sales on Licensed Products or Screening Products.
6.03.1 On sales of Licensed Products or Screening Products by LICENSEE to sublicensees or affiliated parties or on sales made in other than an arm’s-length transaction, the value of the Net Sales attributed under this Article 6.03 to such a transaction shall be that which would have been received in an arm’s-length transaction, based on sales of like quantity and quality products on or about the time of such transaction.
6.03.2 No multiple royalties shall be payable to OHSU because any Licensed Products or Screening Products are covered by more than one of the Patent Rights in this Agreement.
6.03.3 The term of the royalties will be:
  6.03.3.1   For Licensed Products, royalties shall be paid based on the existence of a Valid Claim in the country of intended use.
 
  6.03.3.2   For Screening Products, royalties will be due until the last of the following expire:
  6.03.3.2.1   if OHSU is the assignee on some or all of the inventorship rights on the Screening Product patent under which the royalties are due, royalties shall be paid based on the existence of a Valid Claim in the country of intended use.
 
  6.03.3.2.2   If OHSU is not the assignee on some or all of the inventorship rights on the Screening Product patent under which the royalties are due, royalties are due on the Screening Product in all countries in which the Screening Product patent is maintained until the last to expire of the a) Licensed Mouse Patent Rights or b) Licensed Screening Patent Rights.
6.03.4 Royalties will be paid pursuant to Article 8.02 below.
 
***   Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.